What are the top drugs of Jazz Pharmaceuticals?
Jazz Pharmaceuticals is a prominent global biopharmaceutical company focusing heavily on neuroscience therapeutics, sleep medicine, and innovative oncology treatments. One of its flagship neurological products is Xyrem, followed by its optimized successor Xywav, both of which are widely prescribed blockbusters approved for the treatment of cataplexy and excessive daytime sleepiness associated with narcolepsy, as well as idiopathic hypersomnia. Epidiolex, acquired through major corporate expansion, stands as another foundational product portfolio asset representing the first FDA-approved plant-derived cannabinoid pharmaceutical for treating rare, severe epileptic conditions such as Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. In its oncology franchise, Vyxeos serves as a critical frontline therapy utilizing proprietary liposomal technology for the treatment of high-risk acute myeloid leukemia. Other notable specialized products include Zepzelca for small cell lung cancer and Defitelio for severe hepatic veno-occlusive disease, cementing the company's diversified clinical impact.
Related FAQs
Senior directors overseeing commercial real estate brokerage, corporate solutions, property asset management, or capital markets divisions at Jones Lang LaSalle (JLL) earn lucrative professional packages combining competitive base compensation with p...
Jazz Pharmaceuticals plc (JAZZ) is a global biopharmaceutical enterprise focused on developing life-changing medicines for people with serious neurological and oncological conditions, including flagship sleep medicine and neuroscience treatments.
Jazz Pharmaceuticals operates as a consistently profitable enterprise, generating substantial commercial revenues from its specialized drug portfolio that successfully offset ongoing research and development expenses.
Jazz Pharmaceuticals anticipates an evolving future outlook shaped by the ongoing commercialization of its core neuroscience and oncology franchises, alongside strategic pipeline expansions into next-generation multispecific antibodies.
Lipitor (atorvastatin), manufactured by Pfizer, holds the historical record for generating the highest cumulative sales volume of any pharmaceutical drug ever commercialized.
Jazz Pharmaceuticals is frequently evaluated favorably by Wall Street equity analysts, holding a strong consensus buy rating supported by its diverse portfolio of specialized therapeutics and robust product pipeline.
Oxycodone is a potent opioid analgesic manufactured and distributed by numerous generic and brand-name pharmaceutical companies worldwide.
Jazz Pharmaceuticals operates as a consistently profitable biopharmaceutical enterprise, generating substantial revenues from its commercialized medical portfolio targeting complex neurological and oncological conditions.
Jazz Pharmaceuticals operates in the biopharmaceutical sector focusing on neuroscience and oncology therapeutics, carrying typical clinical and commercial risks.
JBS S.A. distributes regular dividend payments to its eligible shareholders, operating as a massive publicly traded food processing multinational enterprise.
Jazz Pharmaceuticals maintains its primary United States operational headquarters and corporate offices in Palo Alto, California, situated right in the heart of the Silicon Valley biotechnology corridor.
Jazz Pharmaceuticals plc, a global biopharmaceutical enterprise dedicated to developing life-changing medicines for people with serious diseases—particularly within neuroscience and oncology—has its global corporate headquarters located in Dublin, Ir...
Kaleida Health operates with a comprehensive healthcare workforce comprising approximately eight thousand six hundred forty-six employees, functioning as the largest healthcare provider system in Western New York.
Jazz Pharmaceuticals is widely regarded as a strong and reputable biopharmaceutical firm specializing in developing and commercializing life-changing medicines for people with serious and complex diseases, particularly in the therapeutic areas of neu...
Jazz Pharmaceuticals did not originate as a traditional legacy corporate entity with a single prior consumer-facing name, but rather was founded as a specialty biopharmaceutical company that expanded rapidly through strategic corporate acquisitions, ...